Sharps Technology Inc. Purchase Agreements
14 Contracts & Agreements
- Amendment No. 1 to Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on May 24, 2024)
- Purchase Agreement dated May 6, 2024, by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on May 24, 2024)
- Form of the RD Securities Purchase Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Form of the PIPE Securities Purchase Agreement, dated September 27, 2023 (Filed With SEC on October 3, 2023)
- Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Asset Purchase Agreement dated September 22, 2023 by and between the Company and Nephron Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Form of the PIPE Securities Purchase Agreement, dated February 1, 2023 (Filed With SEC on February 6, 2023)
- Amendment to Asset/Share Purchase Agreement, dated April 13, 2022 (Filed With SEC on April 19, 2022)
- Amendment No. 4 to Asset/Share Purchase Agreement, dated July 19, 2021 (Filed With SEC on March 18, 2022)
- Amendment No. 3 to Asset/Share Purchase Agreement, dated October 28, 2020 (Filed With SEC on March 18, 2022)
- Amendment No. 2 to Asset/Share Purchase Agreement, dated August 27, 2020 (Filed With SEC on March 18, 2022)
- Amendment No. 1 to Asset/Share Purchase Agreement, dated June 24, 2020 (Filed With SEC on March 18, 2022)
- Asset/Share Purchase Agreement, dated June 10, 2020, among the Company, Safegard Medical (Hungary) Ktf,, Numan Holding Ltd, Cortrus Services SA and Latitude Investments Limited (Filed With SEC on March 18, 2022)
- Amendment No. 5 to Asset/Share Purchase Agreement, dated February 28, 2022 (Filed With SEC on March 18, 2022)
